Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

219 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Plasma levels of soluble interleukin 1 receptor accessory protein are reduced in obesity.
Bozaoglu K, Attard C, Kulkarni H, Cummings N, Diego VP, Carless MA, Shields KA, Johnson MP, Kowlessur S, Dyer TD, Comuzzie AG, Almasy L, Zimmet P, Moses EK, Göring HH, Curran JE, Blangero J, Jowett JB. Bozaoglu K, et al. Among authors: cummings n. J Clin Endocrinol Metab. 2014 Sep;99(9):3435-43. doi: 10.1210/jc.2013-4475. Epub 2014 Jun 10. J Clin Endocrinol Metab. 2014. PMID: 24915116 Free PMC article.
Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population.
Bozaoglu K, Segal D, Shields KA, Cummings N, Curran JE, Comuzzie AG, Mahaney MC, Rainwater DL, VandeBerg JL, MacCluer JW, Collier G, Blangero J, Walder K, Jowett JB. Bozaoglu K, et al. Among authors: cummings n. J Clin Endocrinol Metab. 2009 Aug;94(8):3085-8. doi: 10.1210/jc.2008-1833. Epub 2009 May 26. J Clin Endocrinol Metab. 2009. PMID: 19470637 Free PMC article.
Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemia.
Powell JA, Lewis AC, Zhu W, Toubia J, Pitman MR, Wallington-Beddoe CT, Moretti PA, Iarossi D, Samaraweera SE, Cummings N, Ramshaw HS, Thomas D, Wei AH, Lopez AF, D'Andrea RJ, Lewis ID, Pitson SM. Powell JA, et al. Among authors: cummings n. Blood. 2017 Feb 9;129(6):771-782. doi: 10.1182/blood-2016-06-720433. Epub 2016 Dec 12. Blood. 2017. PMID: 27956387 Free PMC article.
Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice.
Lee EM, Yee D, Busfield SJ, McManus JF, Cummings N, Vairo G, Wei A, Ramshaw HS, Powell JA, Lopez AF, Lewis ID, McCall MN, Lock RB. Lee EM, et al. Among authors: cummings n. Haematologica. 2015 Jul;100(7):914-26. doi: 10.3324/haematol.2014.113092. Haematologica. 2015. PMID: 26130514 Free PMC article.
The mTOR inhibitor everolimus in combination with azacitidine in patients with relapsed/refractory acute myeloid leukemia: a phase Ib/II study.
Tan P, Tiong IS, Fleming S, Pomilio G, Cummings N, Droogleever M, McManus J, Schwarer A, Catalano J, Patil S, Avery S, Spencer A, Wei A. Tan P, et al. Among authors: cummings n. Oncotarget. 2016 Nov 29;8(32):52269-52280. doi: 10.18632/oncotarget.13699. eCollection 2017 Aug 8. Oncotarget. 2016. PMID: 28881728 Free PMC article.
219 results